| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.32 | 4e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.24 | 2e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.31 | 7e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |